Diligence memo · auto-generated · as of July 2, 2026

Vesper Medical, Inc.

Vesper Medical, Inc. looks under-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Vesper Medical, Inc. operates in Healthtech, based in WAYNE.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Vesper Medical, Inc. has raised $23M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $15M on 2016-10-19.

Most recent recorded round closed around 2019-05-24.

Valuation (modeled)modeled

Provath models Vesper Medical, Inc. at approximately $175M (range $17M–$672M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.39× the median modeled value of Series B Healthtech companies in 2019–2021 (56 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 16 months.

Last raise 7.1 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.3× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 82% of Healthtech peers (2138 compared).

Modeled value ranks above 85% of those peers.

Closest niche peers: Solera Health, Inc., Icebreaker Health, Inc., Buoy Health, Inc., Stroma Medical Corp, HealthJoy, Inc..

Peoplefiled

18 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.